PTGS1: Prostaglandin G/H synthase 1
Dual cyclooxygenase and peroxidase that plays an important role in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)- eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response.
- Drugs that act on it: 3
- Approved: 2
- In phases 1 to 3: 1
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on PTGS1, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 3
| AlclofenacWithdrawn | Approved | — | Small molecule | Inhibitor | 0 |
| Mofezolac | Approved | — | Small molecule | Inhibitor | 0 |
| Antipyrine | Phase 3 | Organon | Small molecule | Inhibitor | 3 |
| Edaravone Dexborneol for Blood-Brain Barrier Repair in Acute Anterior Circulation Stroke | Antipyrine | Phase 4 | Recruiting | Shandong Provincial Hospital | Nov 12, 2026 |
| Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT) | Antipyrine | Phase 4 | Recruiting | Ruijun Ji | Aug 12, 2025 |
| Edaravone in the Treatment of Optic Neuritis | Antipyrine | Not applicable | Recruiting | First Affiliated Hospital of Guangxi Medical University | Sep 14, 2022 |
- Hemorrhage0.63
- Rheumatoid arthritis0.62
- Ulcerative colitis0.61
- Osteoarthritis0.61
- Gout0.61
- Pain0.61
- Dysmenorrhea0.61
- Migraine disorder0.61
- Headache0.61
- Fever0.61
- Juvenile idiopathic arthritis0.60
- Ankylosing spondylitis0.60
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL221, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P23219, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets